RenovoRx Overview

  • Founded
  • 2009
Founded
  • Status
  • Public
  • Employees
  • 8
Employees
  • Stock Symbol
  • RNXT
Stock Symbol
  • Share Price
  • $6.45
  • (As of Friday Closing)

RenovoRx General Information

Description

RenovoRx Inc is a clinical-stage biopharmaceutical company. It is focused on developing therapies for the local treatment of solid tumors and conducting a Phase 3 registrational trial for lead product candidate RenovoGem.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Surgical Devices
Other Industries
Therapeutic Devices
Stock Exchange
NAS
Primary Office
  • 4546 El Camino Real
  • Suite 223
  • Los Altos, CA 94022
  • United States
+1 (650) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

RenovoRx Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$6.45 $6.77 $5.07 - $16.74 $60.3M 8.91M 3.1M -$1.19

RenovoRx Financials Summary

In Thousands,
USD
TTM 30-Sep-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 66,337
Revenue 0 0 0
EBITDA (3,780) (3,211) (3,902)
Net Income (4,847) (3,798) (3,839)
Total Assets 18,178 1,914 2,270
Total Debt 0 2,790 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

RenovoRx Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore RenovoRx‘s full profile, request access.

Request a free trial

RenovoRx Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore RenovoRx‘s full profile, request access.

Request a free trial

RenovoRx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
RenovoRx Inc is a clinical-stage biopharmaceutical company. It is focused on developing therapies for the local treatmen
Surgical Devices
Los Altos, CA
8 As of 2021
000.00
00.00 0000-00-00
00000000 000.00

00000000

uis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure do
00000000 0000000
Marlborough, MA
00 As of 0000
00000
000000 - 000 00000

00000 00

orem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore e
00000000000 0000000
Shelton, CT
000 As of 0000
00000
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

RenovoRx Competitors (26)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CardioFocus Venture Capital-Backed Marlborough, MA 00 00000 000000 - 000 00000
00000 0000 Venture Capital-Backed Shelton, CT 000 00000 00000000000 00000
00000000 0000 0000 Venture Capital-Backed Westminster, CO 00 000.00 00000000000 000.00
0000000000000 Corporation New York, NY 000 000.00 000000 - 000 000.00
000000 Private Equity-Backed Santa Clara, CA 0000 000000000000
You’re viewing 5 of 26 competitors. Get the full list »

RenovoRx Patents

RenovoRx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210268107-A1 Methods and apparatuses for treating tumors Pending 18-May-2017 00000000000
US-20210338977-A1 Methods for treating cancerous tumors Pending 18-May-2017 00000000000
US-20200078555-A1 Methods for treating cancerous tumors Granted 18-May-2017 000000000
US-11052224-B2 Methods for treating cancerous tumors Active 18-May-2017 000000000 000
US-20170157370-A1 Occlusion catheter system and methods of use Granted 03-Jun-2013 A61M25/1011 0

RenovoRx Executive Team (12)

Name Title Board Seat Contact Info
Shaun Bagai Chief Executive Officer & Board Member
Kamran Najmabadi Co-Founder, Chief Technology Officer, Chief Operating Officer & Technical Engineering Advisor
Ramtin Agah MD Chairman & Chief Medical Officer
Paul Manners Vice President
You’re viewing 4 of 12 executive team members. Get the full list »

RenovoRx Board Members (9)

Name Representing Role Since
K. Angela Macfarlane JD Self Board Member 000 0000
Laurence Marton MD Self Board Member 000 0000
Ramtin Agah MD RenovoRx Chairman & Chief Medical Officer 000 0000
Shaun Bagai RenovoRx Chief Executive Officer & Board Member 000 0000
Una Ryan Ph.D Golden Seeds Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »

RenovoRx Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial